(HealthDay)—Underlying leukemia, even before chemotherapy, may pose a neurocognitive risk to young patients, according to a study published online March
Continue reading »Home »
Neurocognitive risk may begin before treatment for young leukemia patients
Leukemia itself, not just side effects related to its treatment, may increase the risk for long-term problems with attention, organization
Continue reading »